Filed: 2/14/2024ACC: 0001012975-24-000089
📋 What this filing means
EUCLIDEAN CAPITAL LLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $888.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$888.54M
Total AUM (reported)
24.40M
Total Shares
Allocation by class
TR UNIT$435.93M49.1%
GOLD SHS$265.73M29.9%
MSCI INDIA ETF$118.37M13.3%
COM$58.33M6.6%
CLASS A COM$9.36M1.1%
COM NEW$824.3K0.1%
*W EXP 08/01/203$3.3K0.0%
Portfolio Concentration
Top 3$820.02M92.3%
4–10$66.83M7.5%
11–25$1.68M0.2%
Top 3 weight
92.3%
Top 10 weight
99.8%
Voting Authority Distribution
Total shares with voting rights: 24.40M
Sole
Full voting authority
24.40M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
SPDR S&P 500 ETF TR
SOLEShares917.14K
TypeSH
Market value$435.93M
49.06%
Sole
917.14K
Shared
0.00
None
0.00
SPDR GOLD TR
SOLEShares1.39M
TypeSH
Market value$265.73M
29.91%
Sole
1.39M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares2.43M
TypeSH
Market value$118.37M
13.32%
Sole
2.43M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares657.90K
TypeSH
Market value$16.35M
1.84%
Sole
657.90K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares1.31M
TypeSH
Market value$10.44M
1.17%
Sole
1.31M
Shared
0.00
None
0.00
FOGHORN THERAPEUTICS INC
SOLEShares1.57M
TypeSH
Market value$10.15M
1.14%
Sole
1.57M
Shared
0.00
None
0.00
23ANDME HOLDING CO
SOLEShares10.24M
TypeSH
Market value$9.36M
1.05%
Sole
10.24M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares989.41K
TypeSH
Market value$9.10M
1.02%
Sole
989.41K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares2.63M
TypeSH
Market value$8.15M
0.92%
Sole
2.63M
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$3.29M
0.37%
Sole
1.02M
Shared
0.00
None
0.00
NGM BIOPHARMACEUTICALS INC
SOLEShares992.17K
TypeSH
Market value$852.3K
0.10%
Sole
992.17K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares87.70K
TypeSH
Market value$824.3K
0.09%
Sole
87.70K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares170.83K
TypeSH
Market value$3.3K
<0.01%
Sole
170.83K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 917.14K | SH | $435.93M 49.06% | 917.14K | 0.00 | 0.00 |
SPDR GOLD TRSOLE | GOLD SHS | 1.39M | SH | $265.73M 29.91% | 1.39M | 0.00 | 0.00 |
ISHARES TRSOLE | MSCI INDIA ETF | 2.43M | SH | $118.37M 13.32% | 2.43M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 657.90K | SH | $16.35M 1.84% | 657.90K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 1.31M | SH | $10.44M 1.17% | 1.31M | 0.00 | 0.00 |
FOGHORN THERAPEUTICS INCSOLE | COM | 1.57M | SH | $10.15M 1.14% | 1.57M | 0.00 | 0.00 |
23ANDME HOLDING COSOLE | CLASS A COM | 10.24M | SH | $9.36M 1.05% | 10.24M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 989.41K | SH | $9.10M 1.02% | 989.41K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 2.63M | SH | $8.15M 0.92% | 2.63M | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 1.02M | SH | $3.29M 0.37% | 1.02M | 0.00 | 0.00 |
NGM BIOPHARMACEUTICALS INCSOLE | COM | 992.17K | SH | $852.3K 0.10% | 992.17K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 87.70K | SH | $824.3K 0.09% | 87.70K | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/203 | 170.83K | SH | $3.3K <0.01% | 170.83K | 0.00 | 0.00 |